The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s diabetic foot ulcer treatment market report forecasts the diabetic foot ulcer treatment market size to grow to $9.41 Billion by 2027, with a CAGR (compound annual growth rate) of more than/nearly/about/almost 8%.

Learn More On The Diabetic Foot Ulcer Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/diabetic-foot-ulcer-treatment-global-market-report

Diabetic Foot Ulcer Treatment Market Size Forecast
The global diabetic foot ulcer treatment market is expected to grow from $6.43 billion in 2022 to $6.93 billion in 2023 at a compound annual growth rate (CAGR) of 7.76%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The diabetic foot ulcer treatment market size is expected to reach $9.41 billion in 2027 at a CAGR of 7.93%.

North America held the largest diabetic foot ulcer treatment market share, and Asia-Pacific was the fastest-growing region in 2022.

Key Diabetic Foot Ulcer Treatment Market Driver ­– Increase In Number Of Diabetes Patients
For instance, in 2022, according to Centers for Disease Control and Prevention, a US-based national public health agency, around 37.3 million people are suffering from diabetes which equals 11.3% of the United States population. Additionally, in December 2021, according to the International Diabetes Federation, a Belgium-based leading global diabetes community approximately 537 million adults are suffering from diabetes globally, whereas 3 out of 4 adults are in low- and middle-income countries. Therefore, the increased number of diabetes patients is driving the growth of the diabetic foot ulcer treatment market.

Request for A Sample Of The Global Diabetic Foot Ulcer Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8082&type=smp

Key Diabetic Foot Ulcer Treatment Market Trend – Technological Advancement
Major market players are focusing on innovative technologies such as cloud-based AI technology for the detection of diabetic foot ulcers. For instance, in October 2021, Manchester Metropolitan University, a UK-based research university technology company, partnered with Oracle Corporation, a US-based multinational computer technology, and database management company, and introduced healthcare technology for diabetic foot problems known as FootSnap AI. FootSnap AI uses a mobile application that uses deep learning technologies to accurately detect ulcers on photos of a patient’s feet with high sensitivity (0.934) and specificity (0.911) in identifying images.

Diabetic Foot Ulcer Treatment Market Segment
1) By Treatment: Wound Care Dressings, Biologics, Therapy Devices, Antibiotic Medications, Other Treatments
2) By Ulcer Type: Neuropathic Ulcers, Ischemic Ulcers, Neuro-Ischemic Ulcers
3) By Grade: Grade 1, Grade 2, Grade 3, Grade 4, Grade 5
4) By End-User: Hospital, Ambulatory Surgery Centre, Other End-Users

Diabetic Foot Ulcer Treatment Market Major Players and Strategies
Major players in the diabetic foot ulcer treatment market are Coloplast A/S, Medtronic PLC., Molnlycke Health Care AB, B. Braun Melsungen AG, Medline Industries Inc., BSN Medical GMBH, Molnlycke Health Care AB, Acelity L.P. Inc., Organogenesis Inc., 3M Healthcare, Smith & Nephew PLC., ConvaTec Inc., Oneness Biotech Co. Ltd., Dipexium Pharmaceuticals Inc., ViroMed Co. Ltd., and FirstString Research Inc.

In October 2021, Bioventus Inc., a US-based company operating in active wound healing, acquired MISONIX Inc for an undisclosed amount. Through this acquisition, Bioventus Inc. aims to strengthen its product portfolio in diabetic foot ulcer treatment and its active healing position. MISONIX Inc. is a US-based company operating in ultrasonic surgical devices and diabetes foot ulcer treatment.

The Diabetic Foot Ulcer Treatment Global Market Report 2023 covers regional data on diabetic foot ulcer treatment market size, diabetic foot ulcer treatment market trends and drivers, opportunities, strategies, and diabetic foot ulcer treatment market competitor analysis. The countries covered in the diabetic foot ulcer treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Diabetic foot ulcer refers to skin soreness with full-thickness skin loss on the foot due to neuropathic and vascular complications in patients suffering from diabetes mellitus, which slowdowns the healing process of sores and makes it prone to infection. Diabetic foot ulcer treatment is used to prevent, treat, and manage foot ulcers caused in diabetic patients to avoid amputation if neglected.

View More Reports Related To The Diabetic Foot Ulcer Treatment Market –
Diabetic Foods Global Market Report 2023
Diabetic Footwear Global Market Report 2023
Digestive Enzymes Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: